Endothelial dysfunction in patients with severe acute pancreatitis: Improved by continuous blood purification therapy

International Journal of Artificial Organs

Volumn 30, Issue 5, 2007, Pages 393-400

  Chen, Z H ^a   Liu, Zhi Hong ^a   Yu, C ^a   Ji, D X ^a   Li, L S ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Continuous veno venous hemofilration; E selectin; Endothelial permeability; Intracellular calcium; Severe acute pancreatitis; Thrombomudulin

Indexed keywords

BLOOD; BLOOD PRESSURE; CALCIUM; CALCIUM COMPOUNDS; GLYCOPROTEINS; PATIENT TREATMENT; PURIFICATION;

BLOOD PURIFICATION; CA 2+; CONTINUOUS VENO-VENOI HEMOFILRATION; E-SELECTIN; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PERMEABILITY; INTRACELLULAR CALCIUM; SELECTINS; SEVERE ACUTE PANCREATITIS; THROMBOMUDULIN;

MONOLAYERS;

BIOLOGICAL MARKER; CALCIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN;

ACUTE PANCREATITIS; ADULT; AGED; APACHE; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HEMODYNAMICS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PERMEABILITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 34447513062     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000506     Document Type: Article

References (20)

1. Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care Med 2003; 7: 130-8.
2. Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 2005; 116: 91-100.
3. Kurosawa S, Galvin JB, Esmon NL. Proteolytic formation and properties of functional domains of thrombomodulin. J Biol Chem 1987; 262: 2206-12.
4. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Cytokines, soluble thrombomodulin and sisseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Tromb Res 1996; 80: 519-26.
5. Paul S, Joseph E, Hamid R: Continuous dialysis as systemic therapy in the critically ill patient? Crit Care Med 2003; 31: 988-89.
6. Chen Y, Liu Z, Chen Z, Ji D, Li L. Restoration of immune homeostasis in patients with SIRS/sepsis receiving continuous blood purification therapy. Am J Soc Nephrol 2003; 14: 789A.
7. Cruz K, Hollenberg SM: Modifying leukocyte endothelial interactions in acute inflammatory models. Crit Care Med 2002; 30: 1924-25.
8. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128: 586-90.
9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovatiove therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 1992; 101: 1644-55.
10. Murphy JT, Duffy SL, Hybki DL, Kamm K. Thrombin-mediated permeability of human microvascular pulmonary endothelia cells is calcium dependent. J Trauma 2001; 50: 213-22.
11. Vandenberghe PA, Ceuppens JL. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods 1990; 127: 197-205.
12. Hernandez-Cruz A, Sala F, Adams PR. Subcellular calcium transients visualized by confocal microscopy in a voltage-clamped vertebrate neuron. Science 1990; 247: 858-62.
13. Carnovale A, Rabitti PG, Manes G, Esposito P, Pacelli L, Uomo G. Mortality in acute pancreatitis: is it an early or a late event? JOP 2005; 6: 438-44.
14. Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001; 16 (suppl 5): S67-72.
15. Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 2005; 67: 653-8.
16. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion, molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157: 776-84.
17. Cowley HC, Heney D, Gearing AJ, Hemingway I, Webster NR. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med 1994; 22: 651-7.
18. Rustom R, Leggat H, Tomura HR, Hay CR, Bone JM. Plasma thrombomodulin in renal disease: effects of renal function and proteinuria. Clin Nephrol 1998; 50: 337-41.
19. Garcia-Fernandez N, Montes R, Purroy A, Rocha E. Hemostatic disturbances in patients with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). Thromb Res 2000; 100: 19-25.
20. Nooteboom A, Van Der Linden CJ, Hendriks T. Tumor necrosis factor-alpha and interleukin-1beta mediate endothelial permeability induced by lipopolysaccharide-stimulated whole blood. Crit Care Med 2002; 30: 2063-8.